×
Entrez Id:
2218
Gene Symbol:
FKTN
FKTN
Fukuyama Type Congenital Muscular Dystrophy
1.000
Biomarker
MGD
A retrotransposal insertion in fukutin is seen in almost all cases of FCMD .
19017726
2009
×
Entrez Id:
2218
Gene Symbol:
FKTN
FKTN
Fukuyama Type Congenital Muscular Dystrophy
1.000
Biomarker
MGD
Fukuyama-type congenital muscular dystrophy (FCMD ), associated with brain malformation due to defects in neuronal migration, is caused by mutations in fukutin .
15837576
2005
×
Entrez Id:
2218
Gene Symbol:
FKTN
FKTN
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITHOUT MENTAL RETARDATION), TYPE B, 4
0.900
Biomarker
MGD
Residual laminin-binding activity and enhanced dystroglycan glycosylation by LARGE in novel model mice to dystroglycanopathy.
19017726
2009
×
Entrez Id:
2218
Gene Symbol:
FKTN
FKTN
Myopathies, Nemaline
0.200
Biomarker
MGD
Residual laminin-binding activity and enhanced dystroglycan glycosylation by LARGE in novel model mice to dystroglycanopathy.
19017726
2009
×
Entrez Id:
2218
Gene Symbol:
FKTN
FKTN
Congenital myopathy (disorder)
0.200
Biomarker
MGD
Residual laminin-binding activity and enhanced dystroglycan glycosylation by LARGE in novel model mice to dystroglycanopathy.
19017726
2009
×
Entrez Id:
2218
Gene Symbol:
FKTN
FKTN
Multi-core congenital myopathy
0.200
Biomarker
MGD
Residual laminin-binding activity and enhanced dystroglycan glycosylation by LARGE in novel model mice to dystroglycanopathy.
19017726
2009
×
Entrez Id:
2218
Gene Symbol:
FKTN
FKTN
Congenital Fiber Type Disproportion
0.200
Biomarker
MGD
Residual laminin-binding activity and enhanced dystroglycan glycosylation by LARGE in novel model mice to dystroglycanopathy.
19017726
2009
×
Entrez Id:
2218
Gene Symbol:
FKTN
FKTN
Central Core Myopathy (disorder)
0.200
Biomarker
MGD
Residual laminin-binding activity and enhanced dystroglycan glycosylation by LARGE in novel model mice to dystroglycanopathy.
19017726
2009
×
Entrez Id:
2218
Gene Symbol:
FKTN
FKTN
Myotubular (centronuclear) myopathy
0.200
Biomarker
MGD
Residual laminin-binding activity and enhanced dystroglycan glycosylation by LARGE in novel model mice to dystroglycanopathy.
19017726
2009
×
Entrez Id:
2218
Gene Symbol:
FKTN
FKTN
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 3
0.200
Biomarker
MGD
Residual laminin-binding activity and enhanced dystroglycan glycosylation by LARGE in novel model mice to dystroglycanopathy.
19017726
2009
×
Entrez Id:
2218
Gene Symbol:
FKTN
FKTN
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1
0.200
Biomarker
MGD
Residual laminin-binding activity and enhanced dystroglycan glycosylation by LARGE in novel model mice to dystroglycanopathy.
19017726
2009
×
Entrez Id:
2218
Gene Symbol:
FKTN
FKTN
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 2
0.200
Biomarker
MGD
Residual laminin-binding activity and enhanced dystroglycan glycosylation by LARGE in novel model mice to dystroglycanopathy.
19017726
2009
×
Entrez Id:
2218
Gene Symbol:
FKTN
FKTN
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14
0.200
Biomarker
MGD
Residual laminin-binding activity and enhanced dystroglycan glycosylation by LARGE in novel model mice to dystroglycanopathy.
19017726
2009
×
Entrez Id:
2218
Gene Symbol:
FKTN
FKTN
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 12
0.200
Biomarker
MGD
Residual laminin-binding activity and enhanced dystroglycan glycosylation by LARGE in novel model mice to dystroglycanopathy.
19017726
2009